JP2021525537A5 - - Google Patents
Info
- Publication number
- JP2021525537A5 JP2021525537A5 JP2020567523A JP2020567523A JP2021525537A5 JP 2021525537 A5 JP2021525537 A5 JP 2021525537A5 JP 2020567523 A JP2020567523 A JP 2020567523A JP 2020567523 A JP2020567523 A JP 2020567523A JP 2021525537 A5 JP2021525537 A5 JP 2021525537A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide complex
- cancer
- trimer
- complex according
- trimer polypeptide
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18382401.0 | 2018-06-06 | ||
| EP18382401 | 2018-06-06 | ||
| PCT/EP2019/064864 WO2019234187A1 (en) | 2018-06-06 | 2019-06-06 | Trimeric polypeptide complexes and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021525537A JP2021525537A (ja) | 2021-09-27 |
| JPWO2019234187A5 JPWO2019234187A5 (https=) | 2022-06-14 |
| JP2021525537A5 true JP2021525537A5 (https=) | 2022-06-14 |
| JP7557377B2 JP7557377B2 (ja) | 2024-09-27 |
Family
ID=62716010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567523A Active JP7557377B2 (ja) | 2018-06-06 | 2019-06-06 | 三量体ポリペプチド複合体およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12454577B2 (https=) |
| EP (1) | EP3802601A1 (https=) |
| JP (1) | JP7557377B2 (https=) |
| CN (1) | CN112566939A (https=) |
| WO (1) | WO2019234187A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021285201A1 (en) * | 2020-06-05 | 2022-11-24 | Pieris Pharmaceuticals Gmbh | Multimeric immunomodulator targeting 4-1BB |
| WO2021249010A1 (en) * | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Coronavirus diagnostic compositions, methods, and uses thereof |
| US20230303664A1 (en) * | 2020-07-29 | 2023-09-28 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Therapeutic and diagnostic vhh antibodies against sars-cov-2 and methods for their enhancement |
| EP3944877A1 (en) * | 2020-07-29 | 2022-02-02 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Nanobodies sars-cov2 |
| EP3957650A1 (en) | 2020-08-17 | 2022-02-23 | Themis Bioscience GmbH | Co-stimulatory 4-1bbl ectodomain polypeptides for immunomodulation |
| WO2022184937A1 (en) * | 2021-03-05 | 2022-09-09 | Leadartis, S.L. | Trimeric polypeptides and uses thereof in the treatment of cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
| CA2155335C (en) | 1993-02-04 | 2001-06-05 | HANS CHRISTIAN THõGERSEN | Improved method for the refolding of proteins |
| ES2701445T3 (es) * | 2010-10-15 | 2019-02-22 | Leadartis S L | Generación de complejos polipeptídicos multifuncionales y multivalentes mediante el dominio de trimerización del colágeno XVIII |
| CN118440206A (zh) | 2014-04-07 | 2024-08-06 | 中外制药株式会社 | 免疫活化抗原结合分子 |
| EP3387014B1 (en) | 2015-12-11 | 2022-01-19 | Leadartis, S.L. | Single chain fusionconstructs comprising multimeric antibody fragments fused to collagen trimerization domains |
| AU2017252233A1 (en) | 2016-04-22 | 2018-11-15 | Alligator Bioscience Ab | Novel bispecific polypeptides against CD137 |
-
2019
- 2019-06-06 CN CN201980052447.4A patent/CN112566939A/zh active Pending
- 2019-06-06 US US16/972,654 patent/US12454577B2/en active Active
- 2019-06-06 JP JP2020567523A patent/JP7557377B2/ja active Active
- 2019-06-06 WO PCT/EP2019/064864 patent/WO2019234187A1/en not_active Ceased
- 2019-06-06 EP EP19731177.2A patent/EP3802601A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525537A5 (https=) | ||
| US10584152B2 (en) | Binding proteins based on di-ubiquitin muteins and methods for generation | |
| AU2016295024B2 (en) | Her2 binding proteins based on di-ubiquitin muteins | |
| JP2019531704A5 (https=) | ||
| JP2015516801A5 (https=) | ||
| JP2020505034A5 (https=) | ||
| JP2020517294A5 (https=) | ||
| CN114539411B (zh) | 一种ror1抗体或其抗原结合片段 | |
| JP2016516789A5 (https=) | ||
| JP2017140051A5 (https=) | ||
| WO2009142773A4 (en) | Multivalent fibronectin based scaffold domain proteins | |
| JP2019511904A5 (https=) | ||
| AU2014314214B2 (en) | Binding polypeptides having a mutated scaffold | |
| US20210206847A1 (en) | Igg1 fc monomer and application thereof | |
| JP2022502015A5 (https=) | ||
| JP2019535315A5 (https=) | ||
| JP2010006705A5 (https=) | ||
| EP3253785A1 (en) | Novel egfr binding proteins | |
| JPWO2022133169A5 (https=) | ||
| JPWO2019234187A5 (https=) | ||
| CN103675294A (zh) | 新的肿瘤血清标志物及其应用 | |
| CN119431572B (zh) | 抗vim纳米抗体及其应用 | |
| Chen et al. | Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro | |
| CN115215938A (zh) | 三特异性抗体及用途 | |
| CN112823168A (zh) | 结合her2的四聚体多肽 |